If a patient has severe hypoglycemia it is mandatory to review dietary practices, insulin injection techniques and timing, and insulin regimen. Exclusion of associated diseases, such as celiac disease ...

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

The patient’s blood glucose values averaged 113 to 214 mg/dL for the next 3 days on these insulin doses, with no hypoglycemia. The patient admitted to eating less than she typically does at home. On ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease or end-stage kidney disease may face more frequent occurrences of ...

The use of continuous glucose monitoring and attendance at a diabetes education appointment appeared to increase the odds of patient improvement. A new report could help identify patients with type 1 ...

New research from the Endocrine Society and Avalere Health finds that clinicians lack the resources to identify, assess and manage patients who are at a high risk of developing hypoglycemia, or ...

While ersodetug missed the Phase 3 primary endpoint of a reduction in hypoglycemia events, Rezolute argued that this goal was ...

Each Baqsimi device includes 1 dose of glucagon and cannot be refused. The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of ...

Severe hypoglycemia may result in changes in mental state, seizures, arrhythmias, coma, and death. End-stage renal disease (ESRD) patients with or without diabetes on renal replacement therapy are at ...

The prevalence and predictors of hypoglycemia in South Korean patients with type 2 diabetes were evaluated using a nationwide healthcare database. Objectives: This study aimed to identify the ...